Search research articles
Contact Us
Filters
Showing results (141-150 of 539) with videos related to
Page
of 54
Sort By:
Research Communications in Chemical Pathology and Pharmacology
|
February 1, 1992
Comparative brain levels of phenylpropanolamine and amphetamine in rats
M G Henderson, R W Fuller
The American Journal of Clinical Nutrition
|
January 1, 1992
Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss
T T Yen, R W Fuller
The Journal of Pharmacy and Pharmacology
|
August 1, 1975
Inability of an inhibitor of amine uptake (Lilly 110140) to block depletion of brain 5-hydroxytrptamine by L-dopa
R W Fuller, K W Perry
Neuropharmacology
|
July 1, 1977
Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain
R W Fuller, K W Perry
Endocrine Research Communications
|
January 1, 1977
Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats
R W Fuller, H D Snoddy
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1985
Effects of antidepressants on uptake and receptor systems in the brain
R W Fuller, D T Wong
Life Sciences
|
January 21, 1985
Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents
R W Fuller, L R Steranka
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1986
Flumezapine, an antagonist of central dopamine and serotonin receptors
R W Fuller, N R Mason
Annals of the New York Academy of Sciences
|
January 1, 1987
The place of animal models and animal experimentation in the study of food intake regulation and obesity in humans
R W Fuller, T T Yen
The Journal of Pharmacy and Pharmacology
|
October 1, 1985
Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats
R W Fuller, H D Snoddy
Page
of 54
Search research articles
Search
Showing results (141-150 of 539) with videos related to
Sort By:
Page
of 54
Research Communications in Chemical Pathology and Pharmacology
|
February 1, 1992
Comparative brain levels of phenylpropanolamine and amphetamine in rats
M G Henderson, R W Fuller
The American Journal of Clinical Nutrition
|
January 1, 1992
Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss
T T Yen, R W Fuller
The Journal of Pharmacy and Pharmacology
|
August 1, 1975
Inability of an inhibitor of amine uptake (Lilly 110140) to block depletion of brain 5-hydroxytrptamine by L-dopa
R W Fuller, K W Perry
Neuropharmacology
|
July 1, 1977
Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain
R W Fuller, K W Perry
Endocrine Research Communications
|
January 1, 1977
Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats
R W Fuller, H D Snoddy
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1985
Effects of antidepressants on uptake and receptor systems in the brain
R W Fuller, D T Wong
Life Sciences
|
January 21, 1985
Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents
R W Fuller, L R Steranka
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1986
Flumezapine, an antagonist of central dopamine and serotonin receptors
R W Fuller, N R Mason
Annals of the New York Academy of Sciences
|
January 1, 1987
The place of animal models and animal experimentation in the study of food intake regulation and obesity in humans
R W Fuller, T T Yen
The Journal of Pharmacy and Pharmacology
|
October 1, 1985
Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats
R W Fuller, H D Snoddy
Page
of 54